Sanofi Pasteur Quadrivalent Influenza Vaccine Pregnancy Registry Protocol

Trial Profile

Sanofi Pasteur Quadrivalent Influenza Vaccine Pregnancy Registry Protocol

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 04 Jul 2017 Last checked against ClinicalTrials.gov record.
    • 28 Jun 2017 Planned End Date changed from 1 Aug 2019 to 3 Nov 2022.
    • 28 Jun 2017 Planned primary completion date changed from 1 Aug 2019 to 3 Nov 2022.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top